Articles dans des revues avec comité de lecture (9)
  1. 1. Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A. O., Darcis, G., Avettand-Fenoel, V., Vanhulle, C., Ait-Ammar, A., Santangelo, M., Plant, E., Douce, V. L., Delacourt, N., Cicilionyte, A., Necsoi, C., Corazza, F., Passaes, C. P. B., Schwartz, C., Bizet, M., Fuks, F., Sáez-Cirión, A., Rouzioux, C., De Wit, S., Berkhout, B., Gautier, V., Rohr, O., & Van Lint, C. (2022). Novel role of UHRF1 in the epigenetic repression of the latent HIV-1. EBioMedicine, 79, 103985. doi:10.1016/j.ebiom.2022.103985
  2. 2. Verdikt, R., & Allard, P. (2021). Metabolo-epigenetics: the interplay of metabolism and epigenetics during early germ cells development. Biology of reproduction, 105(3), 616-624. doi:10.1093/biolre/ioab118
  3. 3. Hamann, M. M., Ehmele, P., Verdikt, R., Bialek-Waldmann, J. J., Virdi, S., Günther, T., Van Lint, C., Grundhoff, A., Hauber, J., & Lange, U. C. (2021). Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene. Virus research, 293, 198260. doi:10.1016/j.virusres.2020.198260
  4. 4. Verdikt, R., Hernalsteens, O., & Van Lint, C. (2021). Epigenetic mechanisms of hiv-1 persistence. Vaccines, 9(5), 514. doi:10.3390/vaccines9050514
  5. 5. Ait-Ammar, A., Kula, A., Darcis, G., Verdikt, R., De Wit, S., Gautier, V., Mallon, P., Marcello, A., Rohr, O., & Van Lint, C. (2020). Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. Frontiers in microbiology, 10, 3060. doi:10.3389/fmicb.2019.03060
  6. 6. Lange, U. C., Verdikt, R., Ait-Ammar, A., & Van Lint, C. (2020). Epigenetic crosstalk in chronic infection with HIV-1. Seminars in Immunopathology. doi:10.1007/s00281-020-00783-3
  7. 7. Verdikt, R., Darcis, G., Aït-Ammar, A., & Van Lint, C. (2019). Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence. Current opinion in virology, 38, 63-69. doi:10.1016/j.coviro.2019.07.004
  8. 8. Kula, A., Delacourt, N., Bouchat, S., Darcis, G., Avettand-Fenoel, V., Verdikt, R., Corazza, F., Necsoi, C. V., Vanhulle, C., Bendoumou, M., Burny, A., De Wit, S., Rouzioux, C., Rohr, O., & Van Lint, C. (2019). Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments. Journal of acquired immune deficiency syndromes, 80(5), 605-613. doi:10.1097/QAI.0000000000001958
  9. 9. Le Douce, V., Forouzanfard, F., Eilebrecht, S., Van Driessche, B., Ait-Ammar, A., Verdikt, R., Kurashige, Y., Marban, C., Gautier, V., Candolfi, E., Benecke, A., Van Lint, C., Rohr, O., & Schwartz, C. (2016). HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1 (C. Van Lint, O. Rohr and C. Schwartz are co-last authors). Scientific Reports, 6, 34920. doi:10.1038/srep34920
    10.   Participations à des congrès et colloques internationaux (38)
  10. 1. Marray, T., Hernalsteens, O., Verdikt, R., Vanhulle, C., Dutilleul, A., Nestola, L., Bendoumou, M., Stiernon, L., Santangelo, M., Cristinelli, S. S., Monceaux, V., Verhasselt, B., Galons, H., Ciuffi, A., Sáez-Cirión, A., Rohr, O., & Van Lint, C. (2024). Role of the pol gene enhancer in HIV-1 transcription and replication in myeloid infected cells. Poster présenté à la conférence BELVIR Symposium 12th Edition.
  11. 2. Plant, E., Vreux, L., Galais, M., Martinelli, V., Nestola, L., Bendoumou, M., Gaete, S., Verdikt, R., Bellefroid, M., Vanhulle, C., Tram, J., Burny, A., Pique, C., Peloponese, J. M., Cheret, A., & Van Lint, C. (2024). Identification of the cellular factor UHRF1 as a new epigenetic repressor of Human T-lymphotropic Virus type 1 (HTLV-1) transcription. Poster présenté à la conférence 12th Annual BELVIR Symposium (December 4th, 2024: Brussels, Belgium).
  12. 3. Stiernon, L., Marray, T., Hernalsteens, O., Verdikt, R., Vanhulle, C., Dutilleul, A., Nestola, L., Cristinelli, S. S., Monceaux, V., Verhasselt, B., Galons, H., Ciuffi, A., Sáez-Cirión, A., Rohr, O., & Van Lint, C. (2024). Role of the pol gene enhancer in HIV-1 transcription and replication in myeloid infected cells. Poster présenté à la conférence 10th HIV cure symposium (22-25 semptember 2025).
    13. << Précédent 1 2 3 4 Suivant >>